Reports for TEVA-NAPROXEN EC
Brand name
TEVA-NAPROXEN EC
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02243313 |
Ingredients
NAPROXEN |
Ingredient Strength
375 MG |
ATC Code
M01AE |
ATC Descriptor
ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-NAPROXEN EC | 100 | Resolved | 2020-03-26 | 2020-05-08 | 109583 |
TEVA-NAPROXEN EC | 100 | Resolved | 2020-09-24 | 2020-10-22 | 124986 |
TEVA-NAPROXEN EC | 100 | Resolved | 2021-12-02 | 2022-02-10 | 150403 |
TEVA-NAPROXEN EC | 100 | Resolved | 2022-12-01 | 2023-04-28 | 176794 |
TEVA-NAPROXEN EC | 100 | Resolved | 2024-01-11 | 2024-03-18 | 215719 |
Showing 1 to 5 of 5
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0